Moleculin Biotech, Inc. Common Stock (MBRX)

$2.72 +9.02%
EARNINGS ANALYTICS
event_upcoming Est. Next Earnings: 2026-08-14 ESTIMATED
search

Across 18 earnings reports since Aug 12, 2021, Moleculin Biotech, Inc. Common Stock (MBRX) has a clear post-earnings pattern. It moves ±59.64% on average after reporting and finishes higher 55.6% of the time. Its largest post-earnings gain was +1018.89% (Mar 22, 2024) and its largest decline was -5.19% (May 14, 2025). The next earnings report is predicted for 2026-08-14 (estimated).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

18

Avg Abs. Movement

±59.64%

Positive %

55.6%

Negative %

44.4%

Historical Earnings Statistics

Date Timing Open High Close Volume Movement % SEC Filing
May 15, 2026 ☀ PRE $2.07 $2.12 $2.12 4,904 -3.85% open_in_new
Mar 19, 2026 ☀ PRE $2.01 $2.01 $2.01 396 -0.99% open_in_new
Aug 13, 2025 ☀ PRE $0.67 $0.69 $0.67 4,200 +2.24% open_in_new
May 14, 2025 ☀ PRE $1.02 $1.02 $1.00 2,093 -5.19% open_in_new
Mar 24, 2025 ☀ PRE $1.10 $1.10 $1.05 1,635 -4.55% open_in_new
Nov 12, 2024 ☀ PRE $2.63 $2.71 $2.71 1,236 +10.16% open_in_new
Aug 14, 2024 ☀ PRE $2.26 $2.26 $2.26 0 +0% open_in_new
May 13, 2024 ☀ PRE $4.72 $4.73 $4.73 510 -0.21% open_in_new
Mar 22, 2024 ☽ POST $0.45 $0.45 $0.45 0 +1018.89% open_in_new
Nov 13, 2023 ☀ PRE $0.59 $0.65 $0.57 7,101 +9.97% open_in_new
Aug 11, 2023 ☀ PRE $0.64 $0.64 $0.64 0 +0% open_in_new
May 11, 2023 ☀ PRE $0.76 $0.76 $0.76 100 -2.8% open_in_new
Mar 23, 2023 ☀ PRE $1.04 $1.04 $1.04 0 +2.45% open_in_new
Nov 10, 2022 ☽ POST $0.92 $0.92 $0.92 100 +0% open_in_new
Aug 15, 2022 ☀ PRE $1.65 $1.65 $1.65 500 +1.23% open_in_new
Mar 25, 2022 ☀ PRE $1.78 $1.78 $1.78 900 +3.49% open_in_new
Nov 12, 2021 ☀ PRE $2.47 $2.48 $2.48 1,315 -3.32% open_in_new
Aug 12, 2021 ☀ PRE $3.10 $3.10 $2.93 2,386 -4.09% open_in_new
event

Earnings Count

18

Total earnings in dataset

trending_up

Avg Abs. Movement

±59.64%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

9 most recent
Form Date Filed View on EDGAR
8-K 20260605 open_in_new SEC.gov
8-K 20260529 open_in_new SEC.gov
8-K 20260526 open_in_new SEC.gov
8-K 20260522 open_in_new SEC.gov
8-K 20260515 open_in_new SEC.gov
10-Q 20260514 open_in_new SEC.gov
8-K 20260513 open_in_new SEC.gov
CORRESP 20260410 open_in_new SEC.gov
UPLOAD 20260402 open_in_new SEC.gov

Frequently asked about MBRX earnings

When does Moleculin Biotech, Inc. Common Stock report earnings next? expand_more

Moleculin Biotech, Inc. Common Stock (MBRX)'s next earnings date is estimated for 2026-08-14. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does MBRX stock move after earnings? expand_more

Over 18 reports, MBRX has moved an average of ±59.64% the session after earnings, closing higher 55.6% of the time.

What was MBRX's biggest post-earnings move? expand_more

MBRX's largest post-earnings gain on record was +1018.89% on Mar 22, 2024, and its largest decline was -5.19% on May 14, 2025.

Where can I find Moleculin Biotech, Inc. Common Stock's SEC filings? expand_more

All of Moleculin Biotech, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers